Clinical Trial Update: A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of HPP404 for weight loss in overweight or obese adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• HPP404

Snippet

Sponsor: High Point Pharmaceuticals, LLC. | Conditions: Obesity, Overweight | Phase 2 | Status: TERMINATED